Tag Archives: Vial Adaptors for Reconstitution Drug Market

Vial Adaptors for Reconstitution Drug Market 2016 – 2024: Autoimmune Diseases to Drive Global Market

Vial Adaptors for Reconstitution Drug Market: Scope and Methodology

This report on the vial adaptors for reconstitution drug market analyzes the current and future prospects of the market globally. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn and volume in terms of million units for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global vial adaptors for reconstitution drug market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

This 155 page report gives readers a comprehensive overview of the vial adaptors for reconstitution drugs market. Browse through 28 data tables and 58 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/vial-adaptors-for-reconstitution-drug-market.html

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global vial adaptors for reconstitution drug market.

Market revenue in terms of US$ Mn and volume in terms of million units for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of cancer and other chronic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Vial Adaptors for Reconstitution Drug Market: Segmentation

Based on product type, the global vial adaptors for reconstitution drug market has been segmented into 13mm vial adaptor and 20mm vial adaptor. The market has been further studied from the point of view of major material. Based on material, the market has been categorized into polycarbonate, silicon, polyethylene teraphthalate glycol, polyethylene, and others. On the basis of therapeutic area, the market has been segmented autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. On the basis of delivery mode, the market has been segmented injection and infusion.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving vial adaptors for reconstitution drugs market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

Vial Adaptors for Reconstitution Drug Market: Geographical and Competitive Dynamics

Geographically, the global vial adaptors for reconstitution drug market has been segmented into five regions: North America, Europe, Asia Pacific, and Rest of World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, China, and Japan.

Key Players Mentioned in the Report are:

The global vial adaptors for reconstitution drug market is consolidated in which relatively small number of companies accounted for majority market share. Major players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc.

 

Advertisements

Vial Adaptors for Reconstitution Drug Market: Rising Incidence of Infectious Diseases Augments Demand for Market

Global Vial Adaptors for Reconstitution Drug Market: Snapshot

The global market for vial adaptors for reconstitution drugs has been experiencing a steady demand as these vial adaptors have come to be the safest solutions for quick transfer for drugs between vials. The demand for these vial adaptors is also expected to shoot up as they are exceptionally cost-effective and come with a reduced the risk of needlestick injuries. The growing prevalence of infectious diseases, widening pool of geriatrics, and increasing safety concerns have all triggered a demand for vial adaptors for reconstitution drugs. According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 mn in 2015 and is expected to reach US$1.3 bn by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.

This 155 page report gives readers a comprehensive overview of the vial adaptors for reconstitution drugs market. Browse through 28 data tables and 58 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/vial-adaptors-for-reconstitution-drug-market.html

Autoimmune Diseases to Drive Global Vial Adaptors for Reconstitution Drug Market

On the basis of therapeutic area, the vial adaptors for reconstitution drug market has been segmented into autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. Currently, the infectious diseases segment holds a major share in the global vial adaptors for reconstitution drug therapeutic area segment. However, the autoimmune diseases segment is expected to show robust growth rate in the coming years. As of 2015, it was the second largest segment in the overall market in terms of revenue. The American Autoimmune Related Diseases Association (AARDA) states that more than 50 million individuals are affected by autoimmune disorders in the U.S. every year. This is expected to drive the autoimmune diseases segment in the coming years.

North America to Remain the Leading Regional Market during Forecast Period

In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Out of these regional markets, North America remained dominant in the global vial adaptors for reconstitution drug market in 2015. Europe followed this lead closely. The high incidence of autoimmune diseases, rising technological advancements, and growing demand for needle-free products likely to support the growth of the vial adaptors for reconstitution drug market in North America. On the other hand, the demand in Europe will be fueled by increasing advancements in healthcare technology amidst rising safety concerns.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving vial adaptors for reconstitution drugs market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

Analysts estimate that Asia Pacific is also likely to be a lucrative market for the vial adaptors for reconstitution drugs during the forecast period. The growing adoption of technology, high prevalence of autoimmune diseases such as diabetes, and increasing adoption of technology are all expected to make a significant contribution to the soaring vial adaptors for reconstitution drug market in Asia Pacific. This regional market will also be propelled by the swelling pool of geriatrics, who are prone to various medical conditions and a vast pool of unmet medical needs. The strengthening economies of Asia Pacific and improving access to healthcare in the region are also likely to augment the demand for vial adaptors for reconstitution drugs.

The key players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc. The market is largely consolidated as major players hold a dominating share.

 

Vial Adaptors for Reconstitution Drug Market: North America to Show Dominance in Global Market as Technological Advancements Gain Momentum

The global vial adaptor for reconstitution drug market is fairly consolidated as top four players hold a leading share in the global market. A report by Transparency Market Research states that West Pharmaceutical Services, Inc., Cardinal Health Inc., Baxter International Inc., and Becton, Dickinson & Company collectively held about 67% in the global market in 2015. These companies are expected to focus on enhancing their product portfolio, expanding their geographical presence, and making strategic acquisitions and mergers to stay ahead of the competition in the coming years.

 The research report states that the global vial adaptors for reconstitution drug market is expected to be worth US$1.3 bn by the end of 2024 as compared to US$780 mn in 2015. During the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.

 This 155 page report gives readers a comprehensive overview of the vial adaptors for reconstitution drugs market. Browse through 28 data tables and 58 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/vial-adaptors-for-reconstitution-drug-market.html

 North America to Show Dominance in Global Market as Technological Advancements Gain Momentum

 In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Of these, North America is anticipated to lead the global vial adaptors for reconstitution drug market in the coming years. The fast-paced technological advancements along with rising demand for needle-free products is expected to benefit the North America vial adaptors for reconstitution drug market. By the end of 2024, this regional market is expected to acquire a share of 45.1% in the global market.

 The various therapeutic areas studied under this report are autoimmune diseases, metabolic conditions, infectious diseases, reproductive health, and others. Of these, the autoimmune diseases segment accounted for the largest share in the global market in 2015. The segment is anticipated to be exhibit a rapid growth rate due to changing lifestyles, environmental variations impacting human health, and modification of genes through the generations that have spiked the prevalence of autoimmune diseases. The autoimmune diseases segment is expected to progress at a CAGR of 7.5% between 2016 and 2024.

 Rising Incidence of Infectious Diseases Augments Demand for Vial Adaptors for Reconstitution Drugs

 The global vial adaptors for reconstitution drug market has been witnessing a spike in demand for products as they are safer options for transferring diluents for reconstitution processes as compared to conventional ways. These also minimize the risk of potential needlestick injury. The market also stands to benefit due to the growing pool of geriatrics, who are susceptible to a wide range of diseases and disorders that require administration of drugs through vial adaptors. Furthermore, the high prevalence of infectious diseases is also likely to augment the demand for reconstitution drugs, which in turn will reflect positively on the demand for vial adaptors required for the same.

 Request a sample of this report to know what opportunities will emerge in the rapidly evolving vial adaptors for reconstitution drugs market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

 The growing demand for lyophilized drugs has also upped the demand for vial adaptors for reconstitution drugs in recent years. The lack of contamination and reduced risk of drug spillage is also expected to drive the rising revenue of the global market all through the forecast period.

 Difficulty in Customizations Hampers Growth of Global Market

 The steady pace of market drivers is likely to face a few hurdles during the forecast period. The key restraint in the global vial adaptors for reconstitution drug market is the need for customization for specific products. This demands wide screening of off-the-shelf deployment of vial adaptors, which is the biggest logistical problem for the global market. The demand for vial adaptors for reconstitution drug market is also being hampered by availability of substitutes such as prefilled syringes and auto-injectors.

 This review is based on Transparency Market Research’s review, titled “Vial Adaptors for Reconstitution Drug Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024.”

 

Vial Adaptors for Reconstitution Drug Market By Analysis of Major Industry Segments 2024

Global Vial Adaptors for Reconstitution Drug Market: Snapshot

The global market for vial adaptors for reconstitution drugs has been experiencing a steady demand as these vial adaptors have come to be the safest solutions for quick transfer for drugs between vials. The demand for these vial adaptors is also expected to shoot up as they are exceptionally cost-effective and come with a reduced the risk of needlestick injuries. The growing prevalence of infectious diseases, widening pool of geriatrics, and increasing safety concerns have all triggered a demand for vial adaptors for reconstitution drugs. According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 mn in 2015 and is expected to reach US$1.3 bn by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.

Read Full Report: http://www.transparencymarketresearch.com/vial-adaptors-for-reconstitution-drug-market.html

Autoimmune Diseases to Drive Global Vial Adaptors for Reconstitution Drug Market

On the basis of therapeutic area, the vial adaptors for reconstitution drug market has been segmented into autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. Currently, the infectious diseases segment holds a major share in the global vial adaptors for reconstitution drug therapeutic area segment. However, the autoimmune diseases segment is expected to show robust growth rate in the coming years. As of 2015, it was the second largest segment in the overall market in terms of revenue. The American Autoimmune Related Diseases Association (AARDA) states that more than 50 million individuals are affected by autoimmune disorders in the U.S. every year. This is expected to drive the autoimmune diseases segment in the coming years.

North America to Remain the Leading Regional Market during Forecast Period

In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Out of these regional markets, North America remained dominant in the global vial adaptors for reconstitution drug market in 2015. Europe followed this lead closely. The high incidence of autoimmune diseases, rising technological advancements, and growing demand for needle-free products likely to support the growth of the vial adaptors for reconstitution drug market in North America. On the other hand, the demand in Europe will be fueled by increasing advancements in healthcare technology amidst rising safety concerns.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

Analysts estimate that Asia Pacific is also likely to be a lucrative market for the vial adaptors for reconstitution drugs during the forecast period. The growing adoption of technology, high prevalence of autoimmune diseases such as diabetes, and increasing adoption of technology are all expected to make a significant contribution to the soaring vial adaptors for reconstitution drug market in Asia Pacific. This regional market will also be propelled by the swelling pool of geriatrics, who are prone to various medical conditions and a vast pool of unmet medical needs. The strengthening economies of Asia Pacific and improving access to healthcare in the region are also likely to augment the demand for vial adaptors for reconstitution drugs.

The key players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc. The market is largely consolidated as major players hold a dominating share.

 

Vial Adaptors for Reconstitution Drug Market to 2024: Trends, Business Strategies and Opportunities with Key Players Analysis

Global Vial Adaptors for Reconstitution Drug Market: Snapshot

The global market for vial adaptors for reconstitution drugs has been experiencing a steady demand as these vial adaptors have come to be the safest solutions for quick transfer for drugs between vials. The demand for these vial adaptors is also expected to shoot up as they are exceptionally cost-effective and come with a reduced the risk of needlestick injuries. The growing prevalence of infectious diseases, widening pool of geriatrics, and increasing safety concerns have all triggered a demand for vial adaptors for reconstitution drugs. According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 mn in 2015 and is expected to reach US$1.3 bn by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.

Read Full Report: http://www.transparencymarketresearch.com/vial-adaptors-for-reconstitution-drug-market.html

Autoimmune Diseases to Drive Global Vial Adaptors for Reconstitution Drug Market

On the basis of therapeutic area, the vial adaptors for reconstitution drug market has been segmented into autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. Currently, the infectious diseases segment holds a major share in the global vial adaptors for reconstitution drug therapeutic area segment. However, the autoimmune diseases segment is expected to show robust growth rate in the coming years. As of 2015, it was the second largest segment in the overall market in terms of revenue. The American Autoimmune Related Diseases Association (AARDA) states that more than 50 million individuals are affected by autoimmune disorders in the U.S. every year. This is expected to drive the autoimmune diseases segment in the coming years.

North America to Remain the Leading Regional Market during Forecast Period

In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Out of these regional markets, North America remained dominant in the global vial adaptors for reconstitution drug market in 2015. Europe followed this lead closely. The high incidence of autoimmune diseases, rising technological advancements, and growing demand for needle-free products likely to support the growth of the vial adaptors for reconstitution drug market in North America. On the other hand, the demand in Europe will be fueled by increasing advancements in healthcare technology amidst rising safety concerns.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

Analysts estimate that Asia Pacific is also likely to be a lucrative market for the vial adaptors for reconstitution drugs during the forecast period. The growing adoption of technology, high prevalence of autoimmune diseases such as diabetes, and increasing adoption of technology are all expected to make a significant contribution to the soaring vial adaptors for reconstitution drug market in Asia Pacific. This regional market will also be propelled by the swelling pool of geriatrics, who are prone to various medical conditions and a vast pool of unmet medical needs. The strengthening economies of Asia Pacific and improving access to healthcare in the region are also likely to augment the demand for vial adaptors for reconstitution drugs.

The key players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc. The market is largely consolidated as major players hold a dominating share.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/